1. Home
  2. ELPC vs RGEN Comparison

ELPC vs RGEN Comparison

Compare ELPC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELPC
  • RGEN
  • Stock Information
  • Founded
  • ELPC 1954
  • RGEN 1981
  • Country
  • ELPC Brazil
  • RGEN United States
  • Employees
  • ELPC N/A
  • RGEN N/A
  • Industry
  • ELPC Electric Utilities: Central
  • RGEN Medical/Dental Instruments
  • Sector
  • ELPC Utilities
  • RGEN Health Care
  • Exchange
  • ELPC Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • ELPC 6.1B
  • RGEN 6.6B
  • IPO Year
  • ELPC N/A
  • RGEN N/A
  • Fundamental
  • Price
  • ELPC $7.97
  • RGEN $118.91
  • Analyst Decision
  • ELPC
  • RGEN Buy
  • Analyst Count
  • ELPC 0
  • RGEN 11
  • Target Price
  • ELPC N/A
  • RGEN $169.33
  • AVG Volume (30 Days)
  • ELPC 7.2K
  • RGEN 995.5K
  • Earning Date
  • ELPC 01-01-0001
  • RGEN 07-29-2025
  • Dividend Yield
  • ELPC 5.02%
  • RGEN N/A
  • EPS Growth
  • ELPC 31.95
  • RGEN N/A
  • EPS
  • ELPC 0.17
  • RGEN N/A
  • Revenue
  • ELPC $4,033,509,015.00
  • RGEN $673,956,000.00
  • Revenue This Year
  • ELPC N/A
  • RGEN $14.14
  • Revenue Next Year
  • ELPC $6.56
  • RGEN $14.32
  • P/E Ratio
  • ELPC $12.12
  • RGEN N/A
  • Revenue Growth
  • ELPC 6.92
  • RGEN 8.73
  • 52 Week Low
  • ELPC $5.04
  • RGEN $102.97
  • 52 Week High
  • ELPC $8.87
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • ELPC 50.25
  • RGEN 46.10
  • Support Level
  • ELPC $7.80
  • RGEN $119.03
  • Resistance Level
  • ELPC $8.02
  • RGEN $132.24
  • Average True Range (ATR)
  • ELPC 0.12
  • RGEN 5.12
  • MACD
  • ELPC 0.01
  • RGEN 0.03
  • Stochastic Oscillator
  • ELPC 82.08
  • RGEN 37.68

About ELPC Companhia Paranaense de Energia (COPEL) (each representing four (4))

Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Services, and Holding. The majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: